Resistance to CD4+CD25+ regulatory T cells and TGF-β in Cbl-b-/- mice

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1059-1065

  Wohlfert, Elizabeth A ^a   Callahan, Margaret K ^a   Clark, Robert B ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CBL PROTEIN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL DIVISION; CELL INTERACTION; CELL STIMULATION; DENDRITIC CELL; DNA SYNTHESIS; EFFECTOR CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION;

EID: 3142782879     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1059     Document Type: Article

References (27)

1. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveira-dos Santos, S. Marlathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403:211.
2. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramua, S. Fukuhara, R.-J. Hu, I. K. Jang, J. S. Gutkind, E. M. Shevach, and H. Gu. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403:216.
3. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in II-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17:167.
4. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
5. + in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100:10878.
6. + regulatory T cells. J. Immunol. 170:3939.
7. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
8. + immunoregulatory cells. J. Immunol. 167:1137.
9. + suppressor T cells. Immunol. Rev. 182:58.
10. + regulatory T cells. J. Immunol. 171:3348.
11. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235.
12. Gregori, S., N. Giarratana, S. Smiroldo, and L. Adorini. 2003. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171:4040.
13. + T cell-mediated suppression by dendritic cells. Science 299:1033.
14. Leveen, P., J. Larsson, M. Ehinger, C. M. Cilio, M. Sundler, L. J. Sjostrand, R. Holmdahl, and S. Karlsson. 2002. Induced disruption of the transforming growth factor β type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 100:560.
15. Johns, L. D., K. C. Flanders, G. E. Ranges, and S. Sriram. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147:1792.
16. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
17. Böttner, M., K. Kerstin Krieglstein, and K. Unsicker. 2000 The transforming growth factor-βs structure, signaling, and roles in nervous system Development and Functions. J. Neurochem. 75:2227.
18. Liu, Y. C., and H. Gu. 2002. Cbl and Cbl-b in T cell regulation. Trends Immunol. 23:140.
19. Zhang, J., T. Bardos, D. Li, I. Gal, C. Vermes, J. Xu, K. Mikecz, A. Finnegan, S. Lipowitz, and T. T. Glant. 2002. Regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169:2236.
20. Yokoi, N., K. Komeda, H. Y. Wang, H. Yano, K. Kitada, Y. Saitoh, Y. Seino, K. Yasuda, T. Serikawa, and S. Seino. 2002. Cbl-b is a major susceptibility gene for rat type 1 diabetes mellitus. Nature 31:391.
21. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. 3:253.
22. + Tr cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111.
23. +high regulatory T cell function. J. Immunol. 169:6210.
24. Bilsborough, G. T. C., J. L. Viney, and A. M. Norment. 2003. High Antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. Eur. J. Immunol. 33:502.
25. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. G. Figdor, K. E. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
26. Joss, A., M. Adkis, A. Faith, K. Blaser, and C. A. Adkis. 2000. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 30:1683.
27. Pearson-White S., and M. McDuffie. 2003. Defective T-cell activation is associated with augmented transforming growth factor β sensitivity in mice with mutations in the Sno gene. Mol. Cell. Biol. 23:5446.